Abenavoli, L.; Scarlata, G.G.M.; Borelli, M.; Suraci, E.; Marasco, R.; Imeneo, M.; Spagnuolo, R.; Luzza, F.
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases. J. Clin. Med. 2025, 14, 2973.
https://doi.org/10.3390/jcm14092973
AMA Style
Abenavoli L, Scarlata GGM, Borelli M, Suraci E, Marasco R, Imeneo M, Spagnuolo R, Luzza F.
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases. Journal of Clinical Medicine. 2025; 14(9):2973.
https://doi.org/10.3390/jcm14092973
Chicago/Turabian Style
Abenavoli, Ludovico, Giuseppe Guido Maria Scarlata, Massimo Borelli, Evelina Suraci, Raffaella Marasco, Maria Imeneo, Rocco Spagnuolo, and Francesco Luzza.
2025. "Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases" Journal of Clinical Medicine 14, no. 9: 2973.
https://doi.org/10.3390/jcm14092973
APA Style
Abenavoli, L., Scarlata, G. G. M., Borelli, M., Suraci, E., Marasco, R., Imeneo, M., Spagnuolo, R., & Luzza, F.
(2025). Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases. Journal of Clinical Medicine, 14(9), 2973.
https://doi.org/10.3390/jcm14092973
